Shares of Becton, Dickinson & Co. continued to slide today after closing down 4% yesterday on news that it's lowering its full-year guidance and a 17% profit slide during its fiscal 1st quarter.
Shares of Becton, Dickinson & Co. (NYSE:BDX) continued their slide today after closing down yesterday following the release of the medical products giant's fiscal 1st quarter results.
Investors, reacting to a lower forecast for the rest of the year and to a nearly 17% profit slide, sent shares down to $77.51 last night, a 3.8% decline. Shares were trading at $76.89 as of about 12:50 p.m. today, down 0.8%.
InspireMD presents new 6 month follow-up data showing better survival rates for its MGuard stent
Symbios Medical Products recalls 2 years' worth of its GoPump systems and GOBlock kits after...
Covidien's MicroStream MicroPod respiratory monitoring module hits the shelves
The newly unveiled iteration of the Microsoft Xbox One's Kinect camera demonstrates the ability to...
If you read nothing else today, make sure you're still in the know with MassDevice +3.